Skip to agency navigation
Skip to main content

Official website

of the Commonwealth of Pennsylvania

    The .gov means it's official.

    Local, state, and federal government websites often end in .gov. Commonwealth of Pennsylvania government websites and email systems use "pennsylvania.gov" or "pa.gov" at the end of the address. Before sharing sensitive or personal information, make sure you're on an official state website. 
    Overdose Prevention

    Overdose Prevention Program

    The Overdose Prevention Program provides free, life-saving supplies to communities across Pennsylvania through local partners, including naloxone to reverse opioid overdoses and test strips to detect fentanyl and xylazine.

    Get supplies for yourself or a loved one
    Get supplies for your organization

    About

    The Overdose Prevention Program's mission is to improve community-based supply distribution and overdose prevention efforts. We aim to reach people at the highest risk of experiencing an overdose.

    This may include:

    • People who use substances
    • People who know someone who uses substances
    • People who access syringe service programs and overdose prevention services

    Overdose Prevention Supplies

    We provide these supplies at no cost:

    • Intranasal naloxone
    • Intramuscular naloxone
    • Fentanyl test strips
    • Xylazine test strips

    Overdose Prevention Partners

    We partner with organizations across Pennsylvania to distribute naloxone and drug testing strips. These overdose prevention partners, formerly recognized entities, serve as a network of local access points.

    “The Overdose Prevention Program has had a direct and meaningful impact on our organization and the community we serve.”

    Partner Feedback

    History

    Pennsylvania's Naloxone for First Responders Program launched in 2017. At a critical point in the opioid epidemic, this program sent out free naloxone kits. The Pennsylvania Commission on Crime and Delinquency (PCCD) led these efforts. That program operated through 2023.

    In partnership with PCCD, we expanded the program in August 2023 to increase access to naloxone and drug testing strips through a network of partners across the Commonwealth.

    DDAP became the lead agency for the program in December 2024.

    Impact

    Since July 2023, the program has: 

    • Distributed over 2.5 million doses of naloxone across Pennsylvania
    • Distributed over 2.1 million fentanyl and xylazine test strips to communities statewide
    • Recorded more than 16,000 reported overdose reversals statewide

    The program expands access to proven overdose prevention tools that help save lives and support pathways to treatment and recovery.

    View the Annual Report for a complete look at the program’s impact
    "One of the individuals we gave naloxone and testing strips to went to a music festival and was able to save two people by administering naloxone. We couldn’t offer naloxone without this program, we have a small budget and could not afford it."

    Partner Feedback

    Contact

    Direct questions or feedback to: